Case-mix adjustment to compare nationwide hospital performances after resection of colorectal liver metastases

Eur J Surg Oncol. 2021 Mar;47(3 Pt B):649-659. doi: 10.1016/j.ejso.2020.10.016. Epub 2020 Oct 16.

Abstract

Background: Differences in patient demographics and disease burden can influence comparison of hospital performances. This study aimed to provide a case-mix model to compare short-term postoperative outcomes for patients undergoing liver resection for colorectal liver metastases (CRLM).

Methods: This retrospective, population-based study included all patients who underwent liver resection for CRLM between 2014 and 2018 in the Netherlands. Variation in case-mix variables between hospitals and influence on postoperative outcomes was assessed using multivariable logistic regression. Primary outcomes were 30-day major morbidity and 30-day mortality. Validation of results was performed on the data from 2019.

Results: In total, 4639 patients were included in 28 hospitals. Major morbidity was 6.2% and mortality was 1.4%. Uncorrected major morbidity ranged from 3.3% to 13.7% and mortality ranged from 0.0% to 5.0%. between hospitals. Significant differences between hospitals were observed for age higher than 80 (0.0%-17.1%, p < 0.001), ASA 3 or higher (3.3%-36.3%, p < 0.001), histopathological parenchymal liver disease (0.0%-47.1%, p < 0.001), history of liver resection (8.1%-36.3%, p < 0.001), major liver resection (6.7%-38.0%, p < 0.001) and synchronous metastases (35.5%-62.1%, p < 0.001). Expected 30-day major morbidity between hospitals ranged from 6.4% to 11.9% and expected 30-day mortality ranged from 0.6% to 2.9%. After case-mix correction no significant outliers concerning major morbidity and mortality remained. Validation on patients who underwent liver resection for CRLM in 2019 affirmed these outcomes.

Conclusion: Case-mix adjustment is a prerequisite to allow for institutional comparison of short-term postoperative outcomes after liver resection for CRLM.

MeSH terms

  • Adenocarcinoma / secondary
  • Adenocarcinoma / surgery*
  • Aged
  • Aged, 80 and over
  • Colorectal Neoplasms / pathology*
  • Fatty Liver / complications
  • Fatty Liver / pathology
  • Female
  • Hepatectomy*
  • Hospitals*
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / pathology
  • Liver Neoplasms / complications
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery*
  • Male
  • Metastasectomy*
  • Middle Aged
  • Mortality
  • Netherlands
  • Postoperative Complications / epidemiology*
  • Quality Assurance, Health Care
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Adjustment*
  • Tertiary Care Centers